Mednet Logo
HomeHospital Medicine
Hospital Medicine

Hospital Medicine

Physician discussions on inpatient care, transitions of care, diagnostic reasoning, and hospital-based protocols.

Recent Discussions

When is it necessary to monitor the QTc interval in patients on hydroxychloroquine?

4
2 Answers

Mednet Member
Mednet Member
Rheumatology · UT Southwestern Medical Center

The answer to this question is not straightforward mainly because there are limited data in this area. Hydroxychloroquine and Chloroquine directly affect cardiac repolarization and are associated with QT prolongation. Given this, there is an argument for getting a baseline ECG for patients initiatin...

Are there any concerns about using nintedanib in a patient with progressive fibrosing ILD on background mycophenolate?

1 Answers

Mednet Member
Mednet Member
Pulmonology · Feinberg School of Medicine

The SENSCIS trial randomized patients with SSc associated ILD to Nintedanib or placebo. I think about half of these patients were still taking MMF. There was no negative signal in the group on MMF and Nintedanib, they fared at least as well as those who got Nintedanib alone and both did better than ...

How would you manage an incidental catheter-related thrombosis in a functioning dialysis catheter?

1
2 Answers

Mednet Member
Mednet Member
Nephrology · Ohio State University Medical Center

If the patient is asymptomatic and the catheter is functioning well, I recommend starting anticoagulation.If the patient develops symptoms, he or she should still be anticoagulated but the catheter removed. Anticoagulation options in ESRD patients include Coumadin, Eliquis (my preference is a dose o...

What is the importance of finding a positive titer for FGFR3 and what treatment would be advised for these patients?

1
1 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

The significance of positive FGFR3 antibodies in patients with neuropathy, and the optimal treatment regimen for those patients remain to be determined. Based on the largest case series of FGFR3-IgG + patients to date, the antibodies seem to be associated predominantly, if not exclusively, with non-...

Are there scenarios where you send additional antibodies beyond anti-centromere, Scl-70, and RNA polymerase III in suspected scleroderma patients?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Georgetown University Medical Center

While these are the most common ANA subtypes in scleroderma, there are several other antibodies that are important. High titer ANA's with a speckled pattern may be U1 RNP and may be associated with overlap disease (MCTD). ANA's with a nucleolar pattern can be U3 RNP (fibrillarin), Th/To, or PM -Scl,...

For low rectal adenocarcinoma that extends to the anus through the internal sphincter muscle, would you recommend neoadjuvant therapy in a patient who will undergo APR?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

Yes, since the margin is positive and local recurrence rates are high for low rectal cancer patients such as this, they should be treated with neoadjuvant chemoradiation including the inguinals with IMRT.

Would you start tocilizumab in a patient with temporal arteritis and cirrhosis?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Massachusetts General Hospital

This is a challenging question as data regarding this question is lacking and the decision should be individualized to the specific presentation and through shared decision making. In general, I would consider using TCZ in such clinical situations. While TCZ can cause hepatotoxicity, it's not typic...

What is your approach following R1 resection in a patient who has received total neoadjuvant therapy for rectal cancer?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic School of Medicine

This is a challenging scenario and there is not a one-size fits all solution. My decision making would involve thorough assessment of the patient's performance status, co-morbidities, pre-treatment extent of disease, tolerance of therapy, and review of what TNT regimen was employed: number of chemo ...

When do you trial pyridostigmine in a patient with suspected myasthenia gravis?

1 Answers

Mednet Member
Mednet Member
Neurology · Yale

I usually try it very early on if I have a reasonable suspicion. Compared to the tensilon test and even the neostigmine test, a diagnostic trial of pyridostigmine is safer and more resource-efficient. Diagnostic trials of pyridostigmine are not particularly evidence-based, nor is treatment, but this...

Would you use inhaled steroids with or without oral steroids for the treatment of radiation pneumonitis?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Montefiore Einstein Comprehensive Cancer Center

I have not tried inhaled steroids instead of oral steroids for symptomatic radiation pneumonitis much in my practice. Many patients are already on inhaled steroids at baseline, and many who develop pneumonitis have severe symptoms. That being said, avoiding oral steroids could be particularly import...